Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 2
1992 4
1993 1
1994 2
1995 3
1996 2
1997 3
1998 2
1999 4
2000 2
2001 4
2003 4
2004 3
2005 2
2007 1
2009 2
2010 1
2011 3
2012 2
2013 2
2014 5
2015 7
2016 6
2017 4
2018 5
2019 3
2020 1
2021 5
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

77 results
Results by year
Filters applied: . Clear all
Page 1
Cystic fibrosis in Austria.
Frischer T, Eber E, Ellemunter H, Zacharasiewicz A, Kaluza I, Riedler J, Renner S. Frischer T, et al. Among authors: ellemunter h. Wien Klin Wochenschr. 2017 Aug;129(15-16):527-532. doi: 10.1007/s00508-017-1179-x. Epub 2017 Feb 24. Wien Klin Wochenschr. 2017. PMID: 28236043
Malignancies in patients with cystic fibrosis: a case series.
Appelt D, Fuchs T, Steinkamp G, Ellemunter H. Appelt D, et al. Among authors: ellemunter h. J Med Case Rep. 2022 Jan 19;16(1):27. doi: 10.1186/s13256-021-03234-1. J Med Case Rep. 2022. PMID: 35042562 Free PMC article.
Insights Into Patient Variability During Ivacaftor-Lumacaftor Therapy in Cystic Fibrosis.
Hanafin PO, Sermet-Gaudelus I, Griese M, Kappler M, Ellemunter H, Schwarz C, Wilson J, Tan M, Velkov T, Rao GG, Schneider-Futschik EK. Hanafin PO, et al. Among authors: ellemunter h. Front Pharmacol. 2021 Aug 2;12:577263. doi: 10.3389/fphar.2021.577263. eCollection 2021. Front Pharmacol. 2021. PMID: 34408649 Free PMC article.
ICln: a chloride channel paramount for cell volume regulation.
Gschwentner M, Susanna A, Schmarda A, Laich A, Nagl UO, Ellemunter H, Deetjen P, Frick J, Paulmichl M. Gschwentner M, et al. Among authors: ellemunter h. J Allergy Clin Immunol. 1996 Nov;98(5 Pt 2):S98-101; discussion S105-6. J Allergy Clin Immunol. 1996. PMID: 8939183 Review.
Genetic Polymorphisms Affecting IDO1 or IDO2 Activity Differently Associate With Aspergillosis in Humans.
Napolioni V, Pariano M, Borghi M, Oikonomou V, Galosi C, De Luca A, Stincardini C, Vacca C, Renga G, Lucidi V, Colombo C, Fiscarelli E, Lass-Flörl C, Carotti A, D'Amico L, Majo F, Russo MC, Ellemunter H, Spolzino A, Mosci P, Brancorsini S, Aversa F, Velardi A, Romani L, Costantini C. Napolioni V, et al. Among authors: ellemunter h. Front Immunol. 2019 May 7;10:890. doi: 10.3389/fimmu.2019.00890. eCollection 2019. Front Immunol. 2019. PMID: 31134053 Free PMC article.
Ivacaftor Reduces Inflammatory Mediators in Upper Airway Lining Fluid From Cystic Fibrosis Patients With a G551D Mutation: Serial Non-Invasive Home-Based Collection of Upper Airway Lining Fluid.
Mainz JG, Arnold C, Wittstock K, Hipler UC, Lehmann T, Zagoya C, Duckstein F, Ellemunter H, Hentschel J. Mainz JG, et al. Among authors: ellemunter h. Front Immunol. 2021 May 5;12:642180. doi: 10.3389/fimmu.2021.642180. eCollection 2021. Front Immunol. 2021. PMID: 34025651 Free PMC article. Clinical Trial.
77 results